Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andres J. Klein-Szanto"'
Autor:
Kathy Q. Cai, Kerry S. Campbell, Tiffany Luong, Tatiana Pazina, Wafik S. El-Deiry, Allison N. Lau, Ruchi Malik, Débora Barbosa Vendramini-Costa, Harvey Hensley, Alexander Muir, Dustin Rollins, Ralph Francescone, Yan Zhou, Siddharth Balachandran, Edna Cukierman, Sapna Gupta, Karthik Devarajan, Warren D. Kruger, Huamin Wang, Roshan J. Thapa, Matthew G. Vander Heiden, Jessica Wagner, Yinfei Tan, Diana Restifo, Andres J. Klein-Szanto, Suraj Peri, Igor Astsaturov, Linara Gabitova, Janusz Franco-Barraza
Publikováno v:
PMC
Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate and lacks effective therapeutics. Therefore, it is of paramount importance to identify new targets. Using multiplex data from patient tissue, three-dimensional coculturing in vit
Autor:
Barbara Burtness, Linara Gabitova, Tetyana V. Bagnyukova, Gregory P. Adams, Kathy Q. Cai, Hanqing Liu, Yan Zhou, Ilya G. Serebriiskii, Anna Sukhanova, Gail E. Herman, Lisa E. Kratz, David Cunningham, Igor Astsaturov, Ranee Mehra, Richard I. Kelley, Diana Restifo, Erica A. Golemis, Andrey Gorin, Brian L. Egleston, Hui Zheng, Louis M. Weiner, Dong-Hua Yang, Anna S. Nikonova, Andres J. Klein-Szanto
Publikováno v:
Cancer Discovery. 3:96-111
Persistent signaling by the oncogenic EGF receptor (EGFR) is a major source of cancer resistance to EGFR targeting. We established that inactivation of 2 sterol biosynthesis pathway genes, SC4MOL (sterol C4-methyl oxidase–like) and its partner, NSD
Autor:
Shoji Natsugoe, Mariusz A. Wasik, Andres J. Klein-Szanto, Yan Li, Zihai Li, Anil K. Rustgi, J. Alan Diehl, Yoshiaki Kita, Yi Yang, Nilesh Chitnis, Hiroshi Nakagawa
Publikováno v:
Cancer discovery. 5(3)
Protein arginine methyltransferase 5 (PRMT5) has been implicated as a key modulator of lymphomagenesis. Whether PRMT5 has overt oncogenic function in the context of leukemia/lymphoma and whether it represents a therapeutic target remains to be establ